CJC-1295/ Ipamorelin 10mg Blend
CJC-1295/ Ipamorelin 10mg Blend
CJC-1295 / Ipamorelin 10mg Blend — Research Grade
This research blend combines CJC-1295 and Ipamorelin into a single 10mg formulation. CJC-1295 is a GHRH analogue that stimulates pulsatile growth hormone release from the pituitary, while Ipamorelin is a selective GHRP that amplifies GH secretion without significantly affecting cortisol or prolactin. Their combined use is studied for synergistic GH axis activation and downstream anabolic and metabolic effects. This product is supplied in lyophilized (powder) form and is intended strictly for in vitro and laboratory research purposes.
Key Research Areas
- Synergistic GHRH and GHRP pathway activation
- Pulsatile GH secretion and pituitary function
- IGF-1 axis regulation and anabolic signaling
- Muscle regeneration and lean body mass research
- Sleep architecture and recovery physiology
Product Details
- Total Concentration: 10mg blend (CJC-1295 / Ipamorelin)
- Purity: Research grade
- Format: Lyophilized powder
- Storage: Store at -20°C; protect from light and moisture
- Reconstitution: Recommended with bacteriostatic water
For research use only. Not intended for human or veterinary use. This product has not been evaluated by the FDA and is not approved for therapeutic or diagnostic use.